Neurocrine Biosciences Inc (NBIX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for NBIX. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 633 institutions reported holding NBIX, with 79.4 million shares worth $11.3 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
BlackRock14,856,103$2.1BINCREASED
Vanguard10,438,588$1.5BINCREASED
Dodge & Cox5,504,578$781MDECREASED
JPMorgan Chase5,292,589$733MDECREASED
State Street4,807,975$682MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Eiry Roberts (Chief Medical Officer)AWARD1,5062026-11-04
Eiry Roberts (Chief Medical Officer)AWARD8,314$1M2026-11-04
MORROW GEORGE J (Director)EXERCISE7,200$386K2026-11-03
MORROW GEORGE J (Director)SELL1,300$219K2026-11-03
MORROW GEORGE J (Director)SELL1,500$252K2026-11-03

Full institutional holdings, insider history, and congressional trades for Neurocrine Biosciences Inc on SentiSense.